Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) dropped 2.5% on Friday . The stock traded as low as $1.85 and last traded at $1.93. Approximately 7,399,037 shares traded hands during trading, a decline of 3% from the average daily volume of 7,652,963 shares. The stock had previously closed at $1.98.
Analyst Ratings Changes
QSI has been the topic of several analyst reports. HC Wainwright reaffirmed a "buy" rating and issued a $5.50 target price on shares of Quantum-Si in a report on Monday, May 19th. Alliance Global Partners reiterated a "buy" rating on shares of Quantum-Si in a research report on Friday, May 16th.
Read Our Latest Analysis on Quantum-Si
Quantum-Si Stock Down 8.7%
The company has a fifty day simple moving average of $1.80 and a two-hundred day simple moving average of $1.63. The company has a market cap of $300.02 million, a price-to-earnings ratio of -2.40 and a beta of 2.89.
Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its quarterly earnings data on Thursday, May 15th. The company reported ($0.11) EPS for the quarter, beating analysts' consensus estimates of ($0.17) by $0.06. The business had revenue of $0.84 million for the quarter, compared to analyst estimates of $0.96 million. Quantum-Si had a negative return on equity of 41.44% and a negative net margin of 2,925.41%. On average, research analysts predict that Quantum-Si Incorporated will post -0.65 EPS for the current year.
Insiders Place Their Bets
In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 23,705 shares of the stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total transaction of $38,165.05. Following the transaction, the chief executive officer directly owned 2,623,011 shares in the company, valued at $4,223,047.71. This represents a 0.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider John S. Vieceli sold 21,923 shares of the firm's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total value of $35,296.03. Following the completion of the sale, the insider owned 842,586 shares in the company, valued at $1,356,563.46. The trade was a 2.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 54,252 shares of company stock worth $87,346. Corporate insiders own 22.95% of the company's stock.
Institutional Investors Weigh In On Quantum-Si
Hedge funds have recently modified their holdings of the stock. Mariner LLC raised its position in Quantum-Si by 29.1% during the fourth quarter. Mariner LLC now owns 33,439 shares of the company's stock valued at $90,000 after buying an additional 7,540 shares during the period. Wells Fargo & Company MN raised its position in Quantum-Si by 13.9% during the fourth quarter. Wells Fargo & Company MN now owns 71,980 shares of the company's stock valued at $194,000 after buying an additional 8,802 shares during the period. Corebridge Financial Inc. raised its position in Quantum-Si by 18.2% during the first quarter. Corebridge Financial Inc. now owns 58,876 shares of the company's stock valued at $71,000 after buying an additional 9,086 shares during the period. ProShare Advisors LLC increased its position in Quantum-Si by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 28,204 shares of the company's stock worth $76,000 after purchasing an additional 9,280 shares during the last quarter. Finally, Commonwealth Equity Services LLC increased its position in Quantum-Si by 46.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 31,013 shares of the company's stock worth $84,000 after purchasing an additional 9,877 shares during the last quarter. 39.90% of the stock is owned by hedge funds and other institutional investors.
About Quantum-Si
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Read More
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.